ABC | Volume 114, Nº2, February 2020

Original Article Martins et al. Mortality from cardiovascular disease and cancer Arq Bras Cardiol. 2020; 114(2):199-206 1. Martins WA; Moço ETM. Cardio-Oncologia: o preço do envelhecimento. Rev Bras Cardiol. 2012;25(3):164-6. 2. Mansur AP, Favarato D. trends in mortality rate from cardiovascular disease in Brazil, 1980-2012. Arq Bras Cardiol. 2016;107(1):20-5. 3. Mansur AP, FavaratoD. Mortality due to cardiovascular diseases in Brazil and in the metropolitan region of São Paulo: a 2011 update. Arq Bras Cardiol. 2012;99(2):755-61. 4. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causesof death, 1990-2013: a systematic analysis for the Global Burden of Disease Study2013. Lancet. 2015;385(9963):117-71. 5. Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, et al . Decline in cardiovascular mortality: possible causes and implications. Circ Res. 2017;120(2):366-80. 6. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al . Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-403. 7. de Souza MF, Alencar AP, Malta DC, Moura L, Mansur AP. Serial temporal analysisof ischemicheartdiseaseandstrokedeathrisk in fiveregionsofBrazil from 1981 to 2001. Arq Bras Cardiol. 2006;87(6):735-40. 8. Instituto Nacional de Câncer José Alencar Gomes da Silva. ABC do câncer: abordagens básicas para o controle do câncer. 2ª ed. rev. ampl. Rio de Janeiro: Inca; 2012. [Internet] 2018. Disponível em: http://bvsms.saude. gov.br/bvs/publicacoes/inca/abc_do_cancer_2ed.pdf. Acesso em 05 de outubro/2018. 9. Driver JA, Djoussé L, Logroscino G, Gaziano JM, Kurth T. Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ. 2008;337:a2467. 10. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al . Explaining the decrease in U.S. deaths from coronary disease,1980-2000. N Engl J Med. 2007;356(23):2388-98. 11. Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, LabartheDR, et al . Cardiovascular risk factor trends and potential for reducing coronary heart diseasemortality in the United States of America. Bull WorldHealthOrgan. 2010;88(2):120-30. 12. Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104-14. 13. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83(2):456S-460S. 14. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Saúde Brasil 2015/2016: Uma análise da situação de saúde e da epidemia pelo vírus Zika e por outras doenças transmitidas pelo Aedes aegypti. Brasília, 2017. Disponível em: http://portalarquivos2.saude.gov.br/images/ pdf/2017/maio/12/2017-0135-vers-eletronica-final.pdf. Acesso em: 05 outubro de 2018. 15. Brasil. Ministério da Saúde. Departamento de Informática do SUS. Informações de saúde (TABNET). [Acesso em 20 maio 2018]. Disponível em: http://datasus.saude.gov.br/informacoes-de-saude/tabnet. 16. JoinPoint Trend Analysis Software. Versão 4.6.0.0. 2018 16 abril; [Cited in 2018 Oct 05]. Available from: https://www.surveillance.cancer.gov/ joinpoint/. 17. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol. 2007;50(22):2128-32. 18. Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Yanfeng LI, et al . Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014;312(12):1218-26. 19. Rosa LV, Issa JS, Salemi VMC, Younes RN, Kalil Filho R. Epidemiologia das doenças cardiovasculares e neoplasias: quando vai ocorrer o cruzamento das curvas? Rev Soc Cardiol Estado de São Paulo.2009;19(4):526-34. 20. Wilson L, Bhatnagar P, Townsend N. Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983-2013: joinpoint regression analysis. Popul Health Metr. 2017;15(1):23. 21. Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015;101(15):1182-9. 22. Smolina K, Wright FL, Rayner M, GoldacreMJ. Determinants of the decline inmortality fromacutemyocardial infarction in England between 2002 and 2010: linked national database study. BMJ. 2012;344:d8059. 23. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004;109(9):1101-7. 24. WeirHK,AndersonRN,ColemanKingSM,SomanA,ThompsonTD,HongY, et al . Heart disease and cancer deaths - trends and projections in the United States, 1969-2020. Prev Chronic Dis. 2016;13:E157. 25. Observatório de Oncologia. Câncer como a primeira causa de morte nos municípios brasileiros. [Acesso em 12 maio 2016]. Disponível em: <https:// observatoriodeoncologia.com.br/cancer-como-a-primeira-causa-de-morte- nos-municipios-brasileiros-em-2015/> Acesso em: 05 de outubro de 2018. 26. Passos VM, Ishitani LH, Franco GC, Lana GC, Abreu DMX, Marinho MF, et al . Consistent declining trends in stroke mortality in Brazil: mission accomplished? Arq Neuropsiquiatr. 2016;74(5):376-81. 27. Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F, Lozano R, et al . Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr. 2010;8:9. 28. LacklandDT, Roccella EJ, Deutsch AF, FornageM, GeorgeMG, HowardG, et al ; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; Council on Functional Genomics and Translational Biology. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45(1):315-53. 29. Mendonça GAS, Bustamante-TeixeiraMT, GuerraMR, Moura L. Tendência e controle do câncer e os 20 anos de Sistema único de Saúde no Brasil. In: Ministério da Saúde. Saúde Brasil 2008: 20 anos de SUS. Brasília; 2009. Série G: Estatística e Informação. 30. Novaes FT, Cataneo DC, Ruiz Junior RL, Defaveri J, Michelin OC, Cataneo AJM. Lung cancer: histology, staging, treatment and survival. J Bras Pneumol. 2008;34(8):595-600. 31. Malta DC, Stopa SR, Santos MAS, Andrade SSCA, Oliveira TP, Cristo EB, et al . Evolution of tobacco use indicators according to telephone surveys, 2006-2014. Cad Saude Publica. 2017;33Suppl 3(Suppl 3):e00134915. 32. Cavalcante TM. O controle do tabagismo no Brasil: avanços e desafios. Rev Psiquiatr Clín.2005;32(5):283-300. 33. Soares LR, Gonzaga CM, Branquinho LW, Sousa AL, Souza MR, Freitas Junior R. Female breast cancer mortality in Brazil according to color. Rev Bras Ginecol Obstet. 2015;37(8):388-92. 34. Jaratlerdsiri W, Chan EKF, Gong T, PetersenDC, Kalsbeek AMF, Venter PA, et al . Whole genome sequencing reveals elevated tumor mutational burden and initiating driver mutations in africanmenwith treatment-naive, high-risk prostate cancer. Cancer Res. 2018. pii: canres.0254.2018. 35. Rocha TAH, Silva NC, Thomaz EBAF, Queiroz RCS, Souza MR, Lein A, et al . Primaryhealthcareandcervicalcancermortalityrates inBrazil:a longitudinal ecological study. J Ambul CareManage. 2017;40(Suppl 2):S24-S34. 36. Campos ZM. Mortalidade por neoplasias do trato genital inferior em Manaus: Estudo de correlação. 86 f. [Tese] Rio de Janeiro: Escola Nacional de Saúde Pública da Fundação Oswaldo Cruz;2004. References 205